ADZENYS ER Trademark

Trademark Overview

On Thursday, September 7, 2017, a trademark application was filed for ADZENYS ER with the United States Patent and Trademark Office. The USPTO has given the ADZENYS ER trademark a serial number of 87599332. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 27, 2025. This trademark is owned by Neos Therapeutics, Inc.. The ADZENYS ER trademark is filed in the Pharmaceutical Products category with the following description:

Prescription pharmaceutical preparations for the treatment of disease and disorders of the central nervous system, excluding pharmaceutical preparations for the prevention and treatment of disorders of the immune system; pharmaceutical preparations for the treatment of cancer; and pharmaceutical preparations for use in oncology
adzenys er

General Information

Serial Number87599332
Word MarkADZENYS ER
Filing DateThursday, September 7, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 27, 2025
Registration Number5628952
Registration DateTuesday, December 11, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2018

Trademark Statements

Goods and ServicesPrescription pharmaceutical preparations for the treatment of disease and disorders of the central nervous system, excluding pharmaceutical preparations for the prevention and treatment of disorders of the immune system; pharmaceutical preparations for the treatment of cancer; and pharmaceutical preparations for use in oncology
NOT AVAILABLE"ER"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 27, 2025
Primary Code005
First Use Anywhere DateMonday, February 12, 2018
First Use In Commerce DateMonday, February 12, 2018

Trademark Owner History

Party NameNeos Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDenver, CO 80237
Party NameNeos Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGrand Prairie, TX 75050
Party NameNeos Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Prairie, TX 75050

Trademark Events

Event DateEvent Description
Thursday, December 14, 2017NON-FINAL ACTION WRITTEN
Monday, September 11, 2017NEW APPLICATION ENTERED
Wednesday, September 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 12, 2017ASSIGNED TO EXAMINER
Tuesday, December 19, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 21, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 5, 2018ASSIGNED TO LIE
Wednesday, January 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 13, 2018PUBLISHED FOR OPPOSITION
Tuesday, February 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, December 14, 2017NON-FINAL ACTION E-MAILED
Thursday, December 14, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 19, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 20, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 10, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 13, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 13, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 9, 2018USE AMENDMENT FILED
Monday, November 5, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 5, 2018STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 7, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 11, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, April 1, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, October 9, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, November 6, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, April 1, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 1, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 1, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 1, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 1, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 10, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 11, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 27, 2025CANCELLED SEC. 8 (6-YR)
Wednesday, September 25, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, October 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 10, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

adzenys pharmaceutical preparations treatment disorders system immune oncology prevention cancer central